The Role of Wearable Technology in Drug Development

The Role of Wearable Technology in Drug Development

How wearable technology can take your drug development programs to the next level

Advanced wearable technology is now embraced by patients, HCPs and regulators. From pre-clinical studies to post-marketing, surveillance has applications across the drug development landscape. So, how and where can wearables best support your clinical research program? How can it deliver a 360-degree view of the patient? What role can it play in the identification of clinical endpoints? In what ways can remote patient monitoring inform late-stage clinical trial planning? For answers, turn to this detailed expert report, The Role of Wearable Technology in Drug Development.

Companies

Novartis, Teva, Roche, AstraZeneca, Sanofi, UCB, Pfizer, Merck, Bristol Myers Squibb, Astellas, Servier, Google, Amazon, PicnicHealth, SK Life Science, Eisai, Bayer, Novo Nordisk, AliveCor, Fitbit, Ada, Apple, Verily Life Sciences, Glooko, Dario, Microsoft, Boehringer Ingelheim, Chugai, Click Therapeutics, Veeva, Withings, Eko, SysNav, Garmin, Hexoskin, Samsung, Dawn Health, Mahana Therapeutics, Theranica, AmerisourceBergen, Movano, Medtronic, Oura Health, Tempus, CytoReason, NVIDIA, Qure.ai, XtalPi, Bellerophon Therapeutics, BlueRock Therapeutics, h2o Therapeutics, Huma, RetinAI Medical, Sanofi Ventures, Viz.ai, Dexcom, Respiree, STAT Health, Xiaomi